As our bodies undergo hormonal shifts during perimenopause and beyond, symptoms like hot flashes, sleep troubles and mood swings are expected. But what’s less discussed is the dryness, discomfort and ...

The FDA granted fast track designation for CTx001, an investigational gene therapy candidate for geographic atrophy secondary ...

Please provide your email address to receive an email when new articles are posted on . I do think that complement therapy can be considered for many patients with geographic atrophy, but the risks ...

DelveInsight’s Geographic Atrophy Market Insightsreport includes a comprehensive understanding of current treatment practices, emerging geographic atrophy drugs, market share of individual therapies, ...

Ocugen, Inc. has completed enrollment in the Phase 2 portion of its clinical trial for OCU410, a novel gene therapy aimed at treating geographic atrophy (GA) associated with dry age-related macular ...

Expert Rev of Obstet Gynecol. 2013;8(5):457-465. While treatments for vulvovaginal atrophy have often focused on the vagina, it is critical to address care for the vulvar vestibule as well. The ...